The pharmaceutical industry has entered a new era of contract manufacturing...
The future of pharma outsourcing depends on partnerships that go beyond the contract. As geopolitical uncertainty, supply chain disruption and increasing market pressures reshape the industry, pharmaceutical companies and CMOs must work together in new ways to balance resilience, agility, innovation and growth.
Pharma Contract Manufacturing 2027 provides a trusted environment for both sides of the partnership to share insights, address common challenges and explore the strategies shaping the next generation of pharma-CDMO collaboration.
Download the 2026 Agenda to see where we left off